SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 78285.07
521.16 (0.67%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Advanced Enzyme Technologies Ltd.	Q V PT	3,615 Small Cap	322.80 (1.43%)	27.42	5.09	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Bajaj Healthcare Ltd.	Q V PT	1,129 Small Cap	335.40 (-2.71%)	52.98	2.12	5.76	2.91	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Gufic Biosciences Ltd.	Q V PT	3,761 Small Cap	375.05 (-4.08%)	59.56	5.66	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Aarti Drugs Ltd.	Q V+ PT	3,464 Small Cap	379.55 (-1.63%)	17.77	2.24	5.74	4.42	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Indraprastha Medical Corporation Ltd.	Q V+ PT	3,496 Small Cap	381.35 (-1.76%)	19.04	4.72	10.30	29.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Gujarat Themis Biosyn Ltd.	Q V+ PT	4,197 Small Cap	385.20 (-0.28%)	89.91	14.59	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Fermenta Biotech Ltd.	Q V PT	1,163 Small Cap	395 (14.21%)	18.08	2.75	7.46	0.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	SMS Pharmaceuticals Ltd.	Q V+ PT	3,935 Small Cap	420.15 (-0.33%)	44.91	4.89	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Biocon Ltd.	Q V PT	69,205 Mid Cap	424.65 (-0.38%)	1860.35	2.56	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	FDC Ltd.	Q V PT	7,000 Small Cap	429.95 (-0.76%)	24.48	2.81	9.23	1.32	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Syngene International Ltd.	Q V+ PT	17,378 Small Cap	430.50 (-2.21%)	57	3.73	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Cohance Lifesciences Ltd.	Q V+ PT	17,323 Small Cap	452.80 (-0.45%)	96.65	4.43	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Unichem Laboratories Ltd.	Q V PT	3,267 Small Cap	464.05 (-1.95%)	20.56	1.25	4.67	-173.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Dr. Agarwals Health Care Ltd.	Q V PT	15,252 Small Cap	481.15 (0.31%)	114.51	7.53	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Bliss GVS Pharma Ltd.	Q V+ PT	5,182 Small Cap	488.65 (-3.46%)	53.5	4.53	9.41	4.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Indegene Ltd.	Q V+ PT	11,907 Small Cap	494.25 (-2.86%)	29.68	3.79	34.59	31.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Panacea Biotec Ltd.	Q V+ PT	3,280 Small Cap	535.55 (-2.56%)	N/A	11.5	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Thyrocare Technologies Ltd.	Q V+ PT	8,677 Small Cap	545.15 (-1.76%)	53.1	14.99	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Krsnaa Diagnostics Ltd.	Q V+ PT	1,788 Small Cap	551.25 (-1.86%)	17.63	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Solara Active Pharma Sciences Ltd.	Q V PT	2,697 Small Cap	559 (-3.09%)	N/A	2.14	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Blue Jet Healthcare Ltd.	Q V PT	9,775 Small Cap	563.50 (1.63%)	39.44	7.19	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Vimta Labs Ltd.	Q V+ PT	2,525 Small Cap	565.15 (-3.45%)	32.58	5.62	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Metropolis Healthcare Ltd.	Q V PT	11,883 Small Cap	573.15 (3.14%)	62.54	7.85	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Shilpa Medicare Ltd.	Q V+ PT	11,650 Small Cap	595.65 (-2.12%)	47.88	4.5	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Lincoln Pharmaceuticals Ltd.	Q V PT	1,230 Small Cap	613.85 (-1.00%)	13.99	1.62	10.63	11.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	9,826 Small Cap	624.30 (-0.30%)	88.02	4.05	10.00	11.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Healthcare Global Enterprises Ltd.	Q V+ PT	9,723 Small Cap	651.25 (-1.06%)	666.89	6.06	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Shree Ganesh Remedies Ltd.	Q V PT	842 Small Cap	655.75 (-2.69%)	47.37	5.16	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Nephrocare Health Services Ltd.	Q V+ PT	6,781 Small Cap	675.80 (0.54%)	N/A	6.98	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Aarti Pharmalabs Ltd.	Q V+ PT	6,409 Small Cap	706.80 (0.09%)	36.37	3.23	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Fermenta Biotech	395	14.21%
Tarsons Products	293.10	10.42%
Sun Pharma Adv. Res	261.65	9.41%
Artemis MedicareServ	276.30	6.11%
Rubicon Research	1,362.85	4.61%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Supriya Lifescience	865.75	-11.62%
Acutaas Chemicals	3,514.30	-4.78%
Gufic Biosciences	375.05	-4.08%
Suven Life Sciences	314.90	-3.86%
Fischer Medical	37.87	-3.66%

News about Top Pharma Companies in India

Jul, 2026

Blue Jet Healthcare informs about resignation of statutory auditors

Blue Jet Healthcare has informed that the Board of Directors of Blue Jet Healthcare at its meeting held on May 25, 2026, has approved the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the notes and schedules thereto and the audit report thereon, including the comparative figures for the financial year ended March 31, 2025, prepared in accordance with the applicable provisions of the Companies Act, 2013 and the applicable accounting standards. A copy of the audited standalone financial statements together with the notes and schedules thereto along with the audit report thereon is enclosed. The audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the notes and schedules thereto and the audit report thereon, are subject to adoption by the shareholders of the Company at the ensuing Annual General Meeting. The above intimation will also be available on the website of the Company, www.bluejethealthcare.com.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Fermenta Biotech informs about press release

Fermenta Biotech has informed that the Company’s Vitamin D3 (Cholecalciferol) - Plant Source has received approval from the Food Safety and Standards Authority of India (FSSAI) for use as an ingredient in Health Supplements, Nutraceuticals and Food Products. ‘Press Release’ issued by the Company in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Fermenta Biotech gets FSSAI’s approval for VITADEE Green

It supports the broader national objective of addressing Vitamin D deficiency through food fortification, an area where regulators have increasingly favoured plant-based sources

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Unichem Laboratories submits AGM notice

Unichem Laboratories has informed that it enclosed Notice of 63rd Annual General Meeting of the Company to be held on Tuesday, 11th August 2026 at 3:30 pm for the financial year 2025-26.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Nectar Lifesciences Ltd.	225 Crore
2	Syncom Formulations (India) Ltd.	1,315 Crore
3	Sigachi Industries Ltd.	844 Crore
4	Fischer Medical Ventures Ltd.	2,479 Crore
5	Morepen Laboratories Ltd.	3,330 Crore
6	Anuh Pharma Ltd.	809 Crore
7	Themis Medicare Ltd.	1,114 Crore
8	Gujarat Kidney And Super Speciality Ltd.	1,010 Crore
9	KMC Speciality Hospitals (India) Ltd.	2,193 Crore
10	IOL Chemicals And Pharmaceuticals Ltd.	4,239 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,852	57,058	36.76	11.95	25.14	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,823	1,63,246	75.46	19.46	39.62	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,371	42,118	39.88	9.31	26.95	25.35
Lupin Ltd. (M)	Somewhat Good	2,492	1,13,963	21.37	5.08	12.36	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,148	1,14,518	22.72	4.40	13.90	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,529	82,615	97.06
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,391	38,385	46.04
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,823	1,63,246	43.21
Aurobindo Pharma Ltd. (M)	Very Good	1,594	91,709	33.87
Gland Pharma Ltd. (S)	Very Good	2,462	40,621	31.41
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,391	38,385	56.94	9.51	34.49	15.51
Mankind Pharma Ltd. (M)	Very Good	2,540	1,04,911	51.49	6.40	32.31	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,371	42,118	39.88	9.31	26.95	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,369	1,14,246	27.23	3.03	15.19	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,823	1,63,246	75.46	19.46	39.62	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,148	1,14,518	22.72	4.40	13.90	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,913	4,59,005	39.98	5.49	22.91	23.50
Abbott India Ltd. (M)	Very Good	26,852	57,058	36.76	11.95	25.14	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,369	1,14,246	27.23	3.03	15.19	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,270	64,072	47.05	6.10	12.50	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Blue Jet Healthcare informs about resignation of statutory auditors

Fermenta Biotech informs about press release

Fermenta Biotech gets FSSAI’s approval for VITADEE Green

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn informs about disclosures

Unichem Laboratories submits AGM notice

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.